Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists

BACKGROUND: Some children with asthma experience exacerbations despite long‐acting beta2‐agonist (LABA) treatment. While this variability is partly caused by genetic variation, no genome‐wide study until now has investigated which genetic factors associated with risk of exacerbations despite LABA us...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Allergy Immunol
Main Authors: Slob, Elise M. A., Richards, Levi B., Vijverberg, Susanne J. H., Longo, Cristina, Koppelman, Gerard H., Pijnenburg, Mariëlle W. H., Bel, Elisabeth H. D., Neerincx, Anne H., Herrera Luis, Esther, Perez‐Garcia, Javier, Tim Chew, Fook, Yie Sio, Yang, Andiappan, Anand K., Turner, Steve W., Mukhopadhyay, Somnath, Palmer, Colin N. A., Hawcutt, Daniel, Jorgensen, Andrea L., Burchard, Esteban G., Hernandez‐Pacheco, Natalia, Pino‐Yanes, Maria, Maitland‐van der Zee, Anke H.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
ORIGINAL ARTICLES
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8328929/
https://ncbi.nlm.nih.gov/pubmed/33706416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.13494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados